Alto Neuroscience, Inc.
Financial highlights
| Metric | FY 12/31/25 | FY 12/31/24 | FY 12/31/23 | FY 12/31/22 |
|---|---|---|---|---|
| Income Statement | ||||
| Operating income | -$66.4 | -$68.6 | -$37.8 | — |
| Net income | -$63.2 | -$61.4 | -$36.3 | — |
| Balance Sheet | ||||
| Total debt | — | $10.0 | — | — |
| Cash Flow Statement | ||||
| Free cash flow | -$51.8 | -$49.5 | -$33.9 | — |
Shares outstanding 39.2M · Free float 84.1%
Annual filing data through FY ended December 31, 2025; float as of October 6, 2026.